According to PTC Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -3.29. At the end of 2024 the company had a P/S ratio of 3.21.
Year | P/S ratio | Change |
---|---|---|
2024 | 3.21 | 44.65% |
2023 | 2.22 | -44.37% |
2022 | 3.99 | -23.76% |
2021 | 5.23 | -52.2% |
2020 | 10.9 | 12.86% |
2019 | 9.69 | 47.71% |
2018 | 6.56 | 84.28% |
2017 | 3.56 | -21.36% |
2016 | 4.53 | -83.83% |
2015 | 28.0 | -62.25% |
2014 | 74.2 | 475.16% |
2013 | 12.9 |